Adapting a Low-threshold Buprenorphine Program for Vulnerable Populations During the COVID-19 Pandemic

Original research
by
Nordeck, Courtney D. et al

Release Date

2021

Geography

USA

Language of Resource

English

Full Text Available

Yes

Open Access / OK to Reproduce

No

Peer Reviewed

Yes

Objective

This paper examines patient characteristics and initial outcomes of patients served during a rapid protocol shift to telehealth that allowed buprenorphine initiation without an in-person encounter following a state-mandated stay-at-home order

Findings/Key points

The PC program illustrates that offering on-demand, flexible treatment is an opportunity to increase opioid use disorder treatment access, even during a public health emergency that disrupted access to services. Relaxation of buprenorphine telehealth regulations allowed for flexibility in treatment and benefits vulnerable populations.

Design/methods

Patient cohort n=143

Keywords

Policy/Regulatory
About prescribers
Outcomes
Substitution/OAT
Digital health